LOGIN
Adverse Events After Adjuvant Radiotherapy for Dupuytren’s Disease: Findings from the DEPART
October 2025
Adverse Events After Adjuvant Radiotherapy for Dupuytren’s Disease: Findings from the DEPART
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Adverse events after adjuvant radiation therapy for Dupuytren's disease in the DEPART randomized trial.
J Hand Surg Eur Vol . 2025 Jul;50(7):891-897.Synopsis
Sixty patients with Dupuytren’s disease were randomized to receive adjuvant radiotherapy (n=28) or observation (n=30) after limited fasciectomy, percutaneous needle fasciotomy, or collagenase injection. The primary outcome of interest was adverse events (AEs) graded by CTCAE. Secondary outcomes of interest included AE prevalence over time, severity distribution, persistence beyond 6–12 months, wou...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.